Financhill
Back

Gilead Sciences Quote, Financials, Valuation and Earnings

Gilead Sciences Price Quote

$72.58
+0.02 (+-1.27%)
(Updated: July 20, 2024 at 6:48 AM ET)

Gilead Sciences Key Stats

Sell
42
Gilead Sciences (GILD) is a Sell

Day range:
$71.96 - $73.74
52-week range:
$62.07 - $87.87
Dividend yield:
4.19%
P/E ratio:
16.12
P/S ratio:
3.32
P/B ratio:
5.15%

Volume:
5.6M
Avg. volume:
8.2M
1-year change:
-8.11%
Market cap:
$90.4B
Revenue:
$27.1B
EPS:
$0.36

How Much Does Gilead Sciences Make?

Is Gilead Sciences Growing As A Company?

  • What Is Gilead Sciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.05%
  • What Is Gilead Sciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Gilead Sciences Stock Price Performance

  • Did Gilead Sciences Stock Go Up Last Month?
    Gilead Sciences share price went up by 14.9% last month
  • Did GILD's Share Price Rise Over The Last Year?
    GILD share price fell by -8.11% over the past 1 year

What Is Gilead Sciences 52-Week High & Low?

Gilead Sciences Price To Free Cash Flow

Is It Risky To Buy Gilead Sciences?

  • How Much Debt Does Gilead Sciences Have?
    Total long term debt quarterly is $25.2B
  • How Much Cash Does Gilead Sciences Have?
    Cash and short term investments quarterly total is $4.7B
  • What Is Gilead Sciences’s Book Value Per Share?
    Book value per share is 14.07

Is Gilead Sciences Cash Flow Positive?

  • What Is GILD Cash Flow From Operations?
    Cash flow from operations (TTM) is $8.5B
  • What Is Gilead Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$5.1B
  • What Is Gilead Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$3.6B

Gilead Sciences Return On Invested Capital

  • Is Management Doing A Good Job?
    GILD return on invested capital is 1.05%
  • What Is Gilead Sciences Return On Assets?
    ROA measures how assets are converting to revenues and is 0.79%
  • What Is GILD Return On Equity?
    ROE is a measure of profitability and is 2.32%

Gilead Sciences Earnings Date & Stock Price

Gilead Sciences Competitors

  • Who Are Gilead Sciences's Competitors?
    Below is a list of companies who compete with Gilead Sciences or are related in some way:
    • AbbVie Inc (ABBV)
    • Amgen Inc (AMGN)
    • Bristol-Myers Squibb Co (BMY)
    • Pfizer Inc (PFE)
    • Arcus Biosciences Inc (RCUS)

Gilead Sciences Dividend Yield

Gilead Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 13.11%
Revenue: 5.26% 5.31%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 16
Sell Recommendations: 0
Price Target: 83.01
Upside from Last Price: 14.4%

Major Shareholders

  • How many GILD shares are owned by institutional investors?
    1.7B GILD shares are owned by institutional investors
  • How many GILD shares are owned by insiders?
    8.4M GILD shares are owned by insiders